Market revenue in 2023 | USD 397.8 million |
Market revenue in 2030 | USD 1,290.2 million |
Growth rate | 18.3% (CAGR from 2023 to 2030) |
Largest segment | Therapeutics |
Fastest growing segment | Diagnostics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diagnostics, Therapeutics |
Key market players worldwide | Roche, Siemens Healthineers AG ADR, Janssen Pharmaceuticals, Illumina Inc, Quest Diagnostics Inc, 23andMe Holding Co Class A, NeoDiagnostix, International Business Machines Corp, Myriad Genetics Inc, Medtronic PLC, GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Dakota Software, Biogen Inc, Qiagen NV, ImmunityBio Inc Ordinary Shares |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to precision medicine market will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 74.74% in 2023. Horizon Databook has segmented the Thailand precision medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
The Excellence Center for Genomics and Precision Medicine at King Chulalongkorn Memorial Hospital has evolved from the Excellence Center of Medicine Genetics, reflecting rapid advances and continuous growth in genetics and genomics over the past decades.
NGS technology, including WES and WGS, is increasingly utilized in medical services. NGS plays a crucial role in many medical fields, leading to more accurate disease diagnosis, better therapeutic and preventive strategies, and overall health promotion. In October 2021, BC Platforms (BCP), a global leader in healthcare data management and analytics, announced an expanded partnership with Bumrungrad International Hospital, one of the largest private hospitals in Southeast Asia.
This partnership, initially formed in February 2019, enhances clinical sample management and automated workflows for genotype-based wellness reporting & NGS-based neonatal screening. Bumrungrad now uses BCP’s Personalized Medicine Platform, powered by BC|GENOME, to implement comprehensive clinical NGS workflows for germline and somatic tumor testing, enabling data-driven personalized care for patients.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand precision medicine market , including forecasts for subscribers. This country databook contains high-level insights into Thailand precision medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account